Difference between revisions of "MSK Biomarker Ctte"
Jump to navigation
Jump to search
Line 5: | Line 5: | ||
The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK. | The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK. | ||
+ | |||
+ | |||
+ | :[[File:MSK_Profile-Wiki_Announcement-2.PNG|700px|link=Profiles]] | ||
Revision as of 19:47, 29 June 2020
- Co-chairs: Thomas M. Link, MD, PhD; Xiaojuan Li, PhD
- RSNA Staff Support: Susan Stanfa
The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.
Meetings
Approved call summaries:
MSK Biomarker Committee Call Summaries Archive
Working Documents
- QIBA MSK Profile 2020-01-28: MR-based cartilage compositional biomarkers (T1ρ, T2) for risk prediction, early diagnosis and monitoring of treatment of degenerative joint disease